|
|
|
Insider
Information: |
Crooke Stanley T |
Relationship: |
Director, 10% Owner |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
2,021 |
|
Indirect Shares
|
7,547,002 |
|
|
Direct
Value |
$80,416 |
|
|
Indirect Value
|
$37,066,880 |
|
|
Total
Shares |
7,549,023 |
|
|
Total
Value |
$37,147,295 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ionis Pharmaceuticals Inc |
IONS |
Exec Chairman of the B... |
2021-01-26 |
2,021 |
2021-01-26 |
497,502 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
7,049,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
463 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 19 of 19
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
IONS |
Ionis Pharmaceuticals Inc |
Chairman, CEO and President |
|
2013-01-16 |
4 |
S |
$14.00 |
$18,438 |
D/D |
(1,317) |
1,661 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
|
2013-07-08 |
4 |
S |
$15.38 |
$384,377 |
D/D |
(24,992) |
26,653 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
|
2014-01-16 |
4 |
S |
$47.08 |
$152,825 |
D/D |
(3,246) |
6,941 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
|
2014-01-16 |
4 |
S |
$47.08 |
$13,230 |
I/I |
(281) |
627 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
|
2015-01-16 |
4 |
S |
$67.96 |
$28,341 |
I/I |
(417) |
1,297 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
|
2015-01-16 |
4 |
S |
$67.96 |
$587,007 |
D/D |
(8,637) |
14,642 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
|
2016-01-19 |
4 |
S |
$41.46 |
$23,882 |
I/I |
(576) |
2,170 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
|
2016-01-19 |
4 |
S |
$41.46 |
$531,716 |
D/D |
(12,825) |
25,029 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
|
2017-01-17 |
4 |
S |
$46.29 |
$26,617 |
I/I |
(575) |
3,062 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
|
2017-01-17 |
4 |
S |
$46.29 |
$712,026 |
D/D |
(15,382) |
38,014 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
|
2018-01-15 |
4 |
S |
$51.76 |
$33,955 |
I/I |
(656) |
4,128 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
|
2018-01-15 |
4 |
S |
$51.76 |
$822,622 |
D/D |
(15,893) |
51,733 |
0 |
- |
|
IONS |
Ionis Pharmaceuticals Inc |
Exec Chairman of the Board |
|
2020-03-17 |
4/A |
S |
$44.50 |
$895,000 |
D/D |
(20,000) |
71,935 |
0 |
- |
|
463 Records found
|
|
Page 19 of 19 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|